Lee et al., 2004 - Google Patents
Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longumLee et al., 2004
View PDF- Document ID
- 16630082783444978028
- Author
- Lee J
- Shin J
- Kim E
- Kang H
- Yim I
- Kim J
- Joo H
- Woo H
- Publication year
- Publication venue
- Journal of veterinary science
External Links
Snippet
14th day. Body weight was decreased with increased survival rate in all groups with the cytoplasm of LABs. Our results showed that cytoplasmic fraction of LABs had direct antiproliferative effects on tumor cell lines in vitro, effects on immune cells in vivo, and …
- 230000001086 cytosolic 0 title abstract description 36
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/96—Cosmetic or similar toilet preparations characterised by the composition containing material, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetic or similar toilet preparations characterised by the composition containing material, or derivatives thereof of undetermined constitution from micro-organisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lee et al. | Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum | |
| US11759486B2 (en) | Lactobacillus plantarum and composition comprising same | |
| Ouwehand et al. | Probiotics: mechanisms and established effects | |
| WO2022218335A1 (en) | Lactobacillus reuteri, and use, composition, drug and food thereof | |
| Fuller | Probiotics 2: applications and practical aspects | |
| CN101171019B (en) | Immune function modulating agents | |
| Lim et al. | Chemopreventive effect of Lactobacttlus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse | |
| Yang et al. | Oral administration of live Bifidobacterium substrains isolated from healthy centenarians enhanced immune function in BALB/c mice | |
| EP2000530A1 (en) | Composition of lactobacillus strains and the application of the composition of lactobacillus strains | |
| Havenaar et al. | Probiotics from an immunological point of view | |
| JP2005529960A (en) | Probiotics, Propionibacterium ienseni 702 | |
| JP5046684B2 (en) | Intestinal barrier function recovery agent and intestinal barrier permeability enhancement inhibitor | |
| Kim et al. | Dietary supplementation of probiotic Bacillus polyfermenticus, Bispan strain, modulates natural killer cell and T cell subset populations and immunoglobulin G levels in human subjects | |
| CN112218646B (en) | A composition and its application | |
| Dogi et al. | Importance of the host specificity in the selection of probiotic bacteria | |
| Yu et al. | Lactobacillus cells in the rabbit digestive tract and the factors affecting their distribution | |
| WO1999017788A1 (en) | Composition of treatment of candidiasis | |
| Faujdar et al. | Role of probiotics in human health and disease: an update | |
| JP2005068092A (en) | Composition for immunostimulation | |
| EP2220210B1 (en) | Strains of lactobacillus plantarum as probiotics with immunomodulatory specific effect | |
| Ostad et al. | Live and heat-inactivated lactobacilli from feces inhibit Salmonella typhi and Escherichia coli adherence to Caco-2 cells | |
| TW201902499A (en) | COMPOSITION FOR ACTIVATING Toll-LIKE RECEPTOR 2 | |
| Nagpal et al. | Probiotics, prebiotics and synbiotics: An introduction | |
| MX2011000658A (en) | Bacteria and derived products to strengthen defences and reduce risk of illness. | |
| Kim et al. | Antitumor activity of Lactobacillus plantarum cytoplasm on teratocarcinoma-bearing mice |